In a significant stride towards early detection and diagnosis of Alzheimer’s disease, Quanterix, a leading biotechnology company, has unveiled a groundbreaking blood test. With Alzheimer’s affecting millions of people worldwide, this innovative diagnostic tool has the potential to revolutionize the way the disease is detected, enabling earlier intervention and improved…